SCHEMBL25599467

SCHEMBL25599467

CC(C)n1ncnc1-c1cc(F)ccc1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.39
NPC1 O15118 1/20 0.39
GABRG2 P18507 4/20 0.37
GABRB3 P28472 4/20 0.37
GABRA5 P31644 4/20 0.37
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
PIK3CA P42336 8/20 0.35
PIK3CD O00329 5/20 0.35
PIK3CB P42338 5/20 0.35
PIK3CG P48736 5/20 0.35
ABL1 P00519 2/20 0.35
EGFR P00533 2/20 0.35
HCK P08631 2/20 0.35
SRC P12931 2/20 0.35
KDR P35968 2/20 0.35
MTOR P42345 2/20 0.35
EPHB4 P54760 2/20 0.35
PRKDC P78527 2/20 0.35
PI4KB Q9UBF8 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25599466 0.80 HTR2A (0.41) PIK3CA
SCHEMBL25783273 0.75 IDO1 (0.43) IDO1NPC1PIK3CDTOP2AKDM1A
SCHEMBL30591318 0.75 IDO1 (0.43) IDO1NPC1PIK3CDTOP2AKDM1A
SCHEMBL25599468 0.74 GABRG2 (0.37) GABRG2GABRB3GABRA5ADRA1DADRA1A
SCHEMBL25599471 0.72 SCN9A (0.35) GABRG2GABRB3GABRA5PIK3CA
SCHEMBL8950307 0.69 ADRA1D (0.41) ADRA1DADRA1APIK3CAPIK3CDPIK3CB
SCHEMBL29519877 0.68 IDO1 (0.44) IDO1NPC1ALDH1A1TOP2A
SCHEMBL19693589 0.68 IDO1 (0.44) IDO1NPC1ALDH1A1TOP2A
SCHEMBL31319263 0.67 IDO1 (0.46) IDO1NPC1ABL1ALDH1A1TOP2A
SCHEMBL8059885 0.67 IDO1 (0.57) IDO1NPC1ALDH1A1TOP2AKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240317748-A1 CARBONYL SUBSTITUTED DIAZASPIRO COMPOUNDS AND ITS USE BIONOVA PHARMACEUTICALS LTD. (KY) 2024-09-26 US disclosed
EP-4271676-A1 CARBONYL SUBSTITUTED DIAZASPIRO COMPOUNDS AND ITS USE Bionova Pharmaceuticals (Shanghai) Limited (CN) 2023-11-08 EP disclosed
CN-116829559-A Carbonyl substituted diazaspiro compounds and uses thereof 烨辉医药科技(上海)有限公司 2023-09-29 CN disclosed
WO-2023098876-A1 CARBONYL SUBSTITUTED DIAZASPIRO COMPOUNDS AND ITS USE BIONOVA PHARMACEUTICALS (SHANGHAI) LIMITED (CN) 2023-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240317748-A1 CARBONYL SUBSTITUTED DIAZASPIRO COMPOUNDS AND ITS USE SDHA, PDHA1, GLS IDO1 3523/4885NPC1 607/4885GABRG2 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.